BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 15545177)

  • 1. Immunohistochemical analysis of molecular biological factors in intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Tanaka M; Manabe T
    Scand J Gastroenterol; 2004 Nov; 39(11):1159-65. PubMed ID: 15545177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and immunohistochemical analysis of malignant features in mucinous cystic tumors of the pancreas.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Hayakawa T; Tanaka M; Takeyama H; Manabe T
    Hepatogastroenterology; 2006; 53(68):286-90. PubMed ID: 16608041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 protein expression in intraductal papillary mucinous tumors (IPMT) of the pancreas as an indicator of tumor malignancy.
    Kawahira H; Kobayashi S; Kaneko K; Asano T; Ochiai T
    Hepatogastroenterology; 2000; 47(34):973-7. PubMed ID: 11020860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical similarities between pancreatic mucinous cystic tumor and ovarian mucinous cystic tumor.
    Suzuki Y; Sugiyama M; Abe N; Fujioka Y; Atomi Y
    Pancreas; 2008 Jan; 36(1):e40-6. PubMed ID: 18192871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of laminin-5-gamma-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas.
    Fukushima N; Sakamoto M; Hirohashi S
    Mod Pathol; 2001 May; 14(5):404-9. PubMed ID: 11353049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of integrins in intraductal papillary-mucinous tumors of the pancreas as an indicator of malignancy.
    Sawai H; Okada Y; Tanaka M; Funahashi H; Hayakawa T; Manabe T
    Pancreas; 2004 Jan; 28(1):20-4. PubMed ID: 14707725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery?
    Jang JY; Kim SW; Ahn YJ; Yoon YS; Choi MG; Lee KU; Han JK; Kim WH; Lee YJ; Kim SC; Han DJ; Kim YI; Choi SH; Cho BH; Yu HC; Yoon DS; Lee WJ; Lee KB; Kim YC; Lee KS; Kim MW; Kim HJ; Kim HJ; Park YH
    Ann Surg Oncol; 2005 Feb; 12(2):124-32. PubMed ID: 15827792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
    Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
    J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas.
    Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M
    Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucinous cystic tumor of the pancreas: immunohistochemical assessment of "ovarian-type stroma".
    Izumo A; Yamaguchi K; Eguchi T; Nishiyama K; Yamamoto H; Yonemasu H; Yao T; Tanaka M; Tsuneyoshi M
    Oncol Rep; 2003; 10(3):515-25. PubMed ID: 12684617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic characteristics of patients with resected multifocal intraductal papillary mucinous neoplasm of the pancreas.
    Fritz S; Schirren M; Klauss M; Bergmann F; Hackert T; Hartwig W; Strobel O; Grenacher L; Büchler MW; Werner J
    Surgery; 2012 Sep; 152(3 Suppl 1):S74-80. PubMed ID: 22770954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles of alterations of p53, p16, and SMAD4 expression in the progression of intraductal papillary-mucinous tumors of the pancreas.
    Sasaki S; Yamamoto H; Kaneto H; Ozeki I; Adachi Y; Takagi H; Matsumoto T; Itoh H; Nagakawa T; Miyakawa H; Muraoka S; Fujinaga A; Suga T; Satoh M; Itoh F; Endo T; Imai K
    Oncol Rep; 2003; 10(1):21-5. PubMed ID: 12469138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
    Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
    J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Problems in histological diagnosis of intraductal papillary-mucinous tumor (IPMT).
    Nagasaka T; Nakashima N
    Hepatogastroenterology; 2001; 48(40):972-6. PubMed ID: 11490851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions.
    Terris B; Dubois S; Buisine MP; Sauvanet A; Ruszniewski P; Aubert JP; Porchet N; Couvelard A; Degott C; Fléjou JF
    J Pathol; 2002 Aug; 197(5):632-7. PubMed ID: 12210083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic study of intraductal papillary-mucinous tumors and mucinous cystic tumors of the pancreas.
    Tanaka M; Sawai H; Okada Y; Yamamoto M; Funahashi H; Takeyama H; Manabe T
    Hepatogastroenterology; 2006; 53(71):783-7. PubMed ID: 17086889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
    Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraductal papillary-mucinous tumors of the pancreas.
    Kubosawa H; Uehara T; Watanabe Y; Urashima T; Matsubara H; Asano T; Ochiai T
    Hepatogastroenterology; 2004; 51(59):1489-94. PubMed ID: 15362784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
    Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S
    J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1 overexpression is the most reliable marker of invasive carcinoma in intraductal papillary-mucinous tumor (IPMT).
    Ueda M; Miura Y; Kunihiro O; Ishikawa T; Ichikawa Y; Endo I; Sekido H; Togo S; Shimada H
    Hepatogastroenterology; 2005; 52(62):398-403. PubMed ID: 15816444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.